RecruitingNCT06247163
PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Prospective PET-guided Radiotherapy for Patients With Small Cell Lung Cancer.
Sponsor
University Hospital, Essen
Enrollment
30 participants
Start Date
Feb 22, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
There is a prospective risk-adapted evaluation of the optimal dose of radiotherapy for definitive radiotherapy of locally advanced small cell lung cancer within the corridor recommended as standard therapy according to the current interdisciplinary S3 guideline of the German Cancer Society/Cancer Aid/AWMF
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Histopathologic confirmation
- Limited disease
Exclusion Criteria5
- Other histology than small cell lung cancer
- Further tumor diagnosis
- ECOG 3 or worse
- Extensive disease
- stage IV
Interventions
RADIATIONPET based Raditherapy boost
An Interim PET CT will be performed. If there is residual vital tumor, a higher radiation dose will be applied.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06247163
Related Trials
Durvalumab After Chemoradiotherapy in Limited Stage Small Cell Lung Cancer.
NCT0699260915 locations
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
NCT070067275 locations
Safety and Efficacy Study of Investigational Agents as Monotherapy or in Combination With Pembrolizumab (MK-3475) for the Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Need of Second-Line Therapy (MK-3475-B98/KEYNOTE-B98)
NCT0493881748 locations
DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers
NCT0588205859 locations
Autologous CAR T-Cells Targeting the GD2 Antigen for Lung Cancer
NCT056203421 location